CRANBURY, N.J.--(BUSINESS WIRE)--OncLive®, the leading digital provider of resources and information to oncology professionals, is pleased to announce that 2018 Giants of Cancer Care® inductee Maurie Markman, M.D., will present the Giants of Cancer Care® Lecture on viewing ovarian cancer as a chronic illness: and increasing need for both therapeutic ‘precision’ and a focus on quality-of-life at this year’s CFS® Chemotherapy Foundation Symposium. The lecture will take place on Thursday, November 8 at 11:10 a.m.
“We are looking forward to listening to Dr. Markman’s presentation at CFS®,” said Michael J. Hennessy Jr, president of MJH Associates, parent company of OncLive®. “He really exemplifies what it means to be a Giant of Cancer Care, and we are very grateful that he has been a part of our advisory board.”
Dr. Markman is currently the president of medicine and science at Cancer Treatment Centers of America (CTCA). Previously, he was senior vice president of clinical affairs and national director of medical oncology. Dr. Markman has more than 20 years of experience in cancer treatment and gynecologic research at some of the country's most recognized facilities. Most recently, Dr. Markman served as the vice president for clinical research, chairman of the department of gynecologic medical oncology at MD Anderson Cancer Center in Houston, Texas, where he also served as a professor of medicine. He is a member of numerous professional organizations, including, but not limited to, the American College of Physicians, the American Society of Clinical Oncology, the American Association for Cancer Research, the American Medical Association, the American Society of Hematology, the American Society of Internal Medicine, the International Gynecologic Cancer Society, and the Society of Gynecologic Oncologists.
The 36th Annual CFS® will take place from November 7- 9 at the New York Marriott Marquis in New York City. At this event, internationally renowned faculty will provide expert insights on the latest developments in cancer therapeutics, offering oncology practitioners an unparalleled opportunity to learn how innovative approaches fit into existing treatment paradigms to optimize care and outcomes for their patients with cancer.
At this year’s Annual CFS®, Giants of Cancer Care® will be exhibiting on the 6th floor where attendee’s will have the chance to nominate their peers who have achieved landmark successes within the global field of oncology. Previous recipients and CFS® faculty include esteemed medical professionals such as Patrick I. Borgen, M.D.; Franco M. Muggia, M.D.; Joyce O'Shaughnessy, M.D.; and Maha H. Hussain, MB, ChB.
“There is no one better to present this year’s Giants of Cancer Care® Lecture at CFS® than Dr. Markman,” said Robert Goldsmith, vice president of OncLive®. “He is a fantastic doctor who will provide expert insights to attendee’s on why there is a need for both therapeutic ‘precision’ and a focus on quality-of-life during his presentation.”
On May 30, 2019, the 2019 Giants of Cancer Care® class of inductees will be celebrated during the annual winners’ reception at the Adler Planetarium in Chicago, Illinois. All nominees are vetted by our seven esteemed Giants of Cancer Care® Advisory Board members, and then voted on by a selection committee of over 115 prominent oncologists.
The nomination process closes on Thursday, February 28, 2019. For more information and to submit a nomination, visit https://www.giantsofcancercare.com/nominate.
A digital platform of resources for practicing oncologists, OncLive® offers oncology professionals information they can use to help provide the best patient care. OncLive.com is the official website for the MJH Associates, Inc., Oncology Specialty Group, which publishes OncologyLive®, Oncology Nursing News® and more. MJH Associates Inc. is a full-service health care communications company offering education, research and medical media, including curetoday.com and CURE® magazine, the largest U.S. consumer publication focused entirely on cancer. Combining science and humanity to make cancer understandable, CURE® reaches patients, cancer centers and advocacy groups.